Benefit of therapeutic drug monitoring to disclose pharmacokinetic interaction between sunitinib and calcium channel blocker

Ann Oncol. 2016 Aug;27(8):1651-2. doi: 10.1093/annonc/mdw182. Epub 2016 Apr 26.

¹ Department of Medical Oncology, Cochin Hospital, AP-HP, Paris Paris Descartes University, CARPEM, Paris.
² Department of Pharmacokinetics and Pharmacochemistry, Cochin Hospital, AP-HP, Paris Paris Descartes University, Paris UMR8638 CNRS, Faculté de Pharmacie, Université Paris Descartes, PRES Sorbonne Paris Cité, Paris, France.
³ Department of Pharmacokinetics and Pharmacochemistry, Cochin Hospital, AP-HP, Paris Paris Descartes University, Paris [email protected].

No abstract available

Publication types